[Pathogenesis of pancreatic carcinoma].
Schmid
R M
RM
II Medizinische Klinik und Poliklinik, Klinikum rechts der Isar, Technische Universität München.
D000818:Animals; D002453:Cell Cycle / Q000235:genetics; D002471:Cell Transformation, Neoplastic / Q000235:genetics* / Q000473:pathology; D019941:Cyclin-Dependent Kinase Inhibitor p16 / Q000235:genetics; D004252:DNA Mutational Analysis; D018450:Disease Progression; D015972:Gene Expression Regulation, Neoplastic / Q000502:physiology; D016153:Genes, Suppressor; D006801:Humans; D010179:Pancreas / Q000473:pathology; D010190:Pancreatic Neoplasms / Q000235:genetics* / Q000473:pathology; D016283:Proto-Oncogene Proteins p21(ras) / Q000235:genetics
D019941:Cyclin-Dependent Kinase Inhibitor p16; C501009:HRAS protein, human; D016283:Proto-Oncogene Proteins p21(ras)